Skip to main content
Clinical Trials/NL-OMON39581
NL-OMON39581
Completed
N/A

MRI Investigation in Transcatheter Aortic Valve replacement with Claret: a randomized study to assess by MRI the reduction in cerebral embolic lesions during Transcatheter Aortic Valve Replacement with the Claret embolic protection device - MISTRAL-C

Overview

Phase
N/A
Intervention
Not specified
Conditions
cerebral embolism
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
54
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with severe AS at high operative risk who will undergo planned TAVI
  • 2\) Informed consent to participate in the study (i.e. use of Claret device yes or no) and undergo DW \-MRI before and after the procedure.
  • 3\) Compatible left common carotid artery (\>\= 5 mm) and brachiocephalic artery (\>\= 9 mm)
  • diameters without significant stenosis (\> 70%) as determined by Multi\-Slice Computed
  • Tomography (MSCT) scan

Exclusion Criteria

  • 1\) No written informed consent
  • 2\) Standard exclusion criteria for MRI study (see Appendix 4\)
  • 3\) Anatomical exclusion for filter deployment
  • 4\) Permanent Pacemaker/AICD in situ before TAVI
  • 5\) Planned implantation of a pacemaker implantation after TAVI.
  • 6\) Previous stroke with residual neurological symptoms or dementia
  • 7\) Not native Dutch speaking

Outcomes

Primary Outcomes

Not specified

Similar Trials